- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 11 - Optimizing Outcomes in Type 2 Diabetes Mellitus
Peter Salgo, MD, notes that the patient adherence rate to therapy for type 2 diabetes mellitus (T2DM) is less than 60 percent. Dr Salgo states that weight loss has been associated with improvement in adherence rate to T2DM therapy, as demonstrated by the SHIELD study. Dr Salgo and Maria Lopes, MD, MS, comment that short-term weight loss success can be a powerful motivator.
Dr Lopes remarks that although weight loss can help keep patients focused, support from the team of healthcare professionals involved in a patient’s care is also important. Dr Lopes comments that patient-centered approaches are effective, and innovative health information technology tools have been developed to help reach patients.
Kari Uusinarkaus, MD, FAAFP, FNLA, discusses the strategies that Colorado Springs Health Partners has implemented to help improve patient adherence, and Jeffrey D. Dunn, PharmD, MBA, describes managed care’s unique position when addressing adherence issues in T2DM.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More
